Light at the end of the tunnel?
Pittsburgh, PA, USA.
Mark A
MA
Sperling
D002648:Child; D003713:Dendritic Cells / Q000276:immunology; D003920:Diabetes Mellitus / Q000453:epidemiology*; D003922:Diabetes Mellitus, Type 1 / Q000453:epidemiology* / Q000276:immunology / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology* / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D011322:Primary Prevention; D012307:Risk Factors
D007155:Immunologic Factors